ARG Strategic Advisory Board Meeting 5/24
The ARG SAB (Strategic Advisory Board) regularly convenes to discuss emerging trends and issues in rare diseases, adding to the spirit of innovation that is…
The ARG SAB (Strategic Advisory Board) regularly convenes to discuss emerging trends and issues in rare diseases, adding to the spirit of innovation that is…
Jeff Cazeault, Head of Business Development at ARG, is in Washington, DC to attend the Alliance for Regenerative Medicine Annual Dinner & Legislative Fly-In. Of…
Shay Brill, ARG Vice President of Corporate Development, recently had the privilege and distinction of serving as a judge in the PharmaTimes Clinical Researcher of…
Three ARG team members attended 2018 Rare Disease Week on Capitol Hill: Senior Data Manager Darlene Adams, Project Manager Catherine Allen, and Director of Corporate…
One of the main reasons why ARG has consistently produced excellent clinical trial work over the years has been because we focus on attracting and…